Literature DB >> 23490085

Liver tissue engineering and cell sources: issues and challenges.

Anwar A Palakkan1, David C Hay, P R Anil Kumar, T V Kumary, James A Ross.   

Abstract

Liver diseases are of major concern as they now account for millions of deaths annually. As a result of the increased incidence of liver disease, many patients die on the transplant waiting list, before a donor organ becomes available. To meet the huge demand for donor liver, alternative approaches using liver tissue engineering principles are being actively pursued. Even though adult hepatocytes, the primary cells of the liver are most preferred for tissue engineering of liver, their limited availability, isolation from diseased organs, lack of in vitro propagation and deterioration of function acts as a major drawback to their use. Various approaches have been taken to prevent the functional deterioration of hepatocytes including the provision of an adequate extracellular matrix and co-culture with non-parenchymal cells of liver. Great progress has also been made to differentiate human stem cells to hepatocytes and to use them for liver tissue engineering applications. This review provides an overview of recent challenges, issues and cell sources with regard to liver tissue engineering.
© 2013 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23490085     DOI: 10.1111/liv.12134

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  27 in total

1.  Advancements in in vitro hepatic models: application for drug screening and therapeutics.

Authors:  Apeksha Damania; Era Jain; Ashok Kumar
Journal:  Hepatol Int       Date:  2013-12-05       Impact factor: 6.047

2.  Pluripotent stem cells to hepatocytes, the journey so far.

Authors:  Anwar A Palakkan; Jyoti Nanda; James A Ross
Journal:  Biomed Rep       Date:  2017-03-01

3.  Orthotopic transplantation of decellularized liver scaffold in mice.

Authors:  Hongyu Zhang; Yujun Zhang; Fengxi Ma; Ping Bie; Lianhua Bai
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

Authors:  Jun Wang; Hao Wang; Jiong Shi; Yitao Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Analysis of determinant factors of liver fibrosis progression in ex-thalassemic patients.

Authors:  Tahereh Rostami; Seyed Mostafa Monzavi; Hossein Poustchi; Ali Reza Khoshdel; Maryam Behfar; Amir Ali Hamidieh
Journal:  Int J Hematol       Date:  2020-10-08       Impact factor: 2.490

Review 6.  Ectopic transplantation sites for cell-based therapy.

Authors:  Aaron D DeWard; Junji Komori; Eric Lagasse
Journal:  Curr Opin Organ Transplant       Date:  2014-04       Impact factor: 2.640

7.  Exploring donor demographics effects on hepatocyte yield and viability: Results of whole human liver isolation from one center.

Authors:  Sharon Geerts; Sinan Ozer; Chris Chu; Bryan C Fuchs; Kenneth K Tanabe; Heidi Yeh; Korkut Uygun
Journal:  Technology (Singap World Sci)       Date:  2019-04-26

8.  Microfluidic device for rapid digestion of tissues into cellular suspensions.

Authors:  Xiaolong Qiu; Trisha M Westerhof; Amrith A Karunaratne; Erik M Werner; Pedram P Pourfard; Edward L Nelson; Elliot E Hui; Jered B Haun
Journal:  Lab Chip       Date:  2017-09-26       Impact factor: 6.799

9.  Photocrosslinked ultrathin anionic polysaccharide supports for accelerated growth of human mesenchymal stem cells.

Authors:  A Mikulska; J Filipowska; A M Osyczka; M Szuwarzyński; M Nowakowska; K Szczubiałka
Journal:  Cell Prolif       Date:  2014-06-25       Impact factor: 6.831

10.  A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat.

Authors:  An Wang; Isabel Jank; Weiwei Wei; Claudia Schindler; Uta Dahmen
Journal:  J Vis Exp       Date:  2018-10-06       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.